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The use of redox polymers in labelling
procedures of proteins and peptides
with 99mTc
II. Technique of preparation of kits for protein labelling by 99mTc and its effect
on the stability and radiochemical purity
virtually the same (9698%) after 30 hours while it is about 45%
with the routine method using stannous chloride. The stability
of protein-containing kits prepared using redox polymers was
improved; the labelling efficiency of HLD and IgG after 300 days
of kit storage was over 97% and 87%, respectively.
CONCLUSIONS: The labelling procedure using redox polymers
can be used in formulating protein- and peptide-based radiop-
harmaceuticals to improve their stability and 99mTc labelling effi-
ciency.
Key words: redox polymers, technetium (99mTc), radioassay,
labelled proteins
Introduction
The issue of labelling of proteins and peptides of labile structures
is very extensive and complex, and has not yet been fully explored.
Currently, small proteins are often employed whose structures in
preparation and labelling are sensitive to reaction conditions.
Generally, the procedures for preparing and labelling of small pro-
teins and peptides can be classified into two main groups (1):
1) methods of direct labelling (2, 3),
2) methods of indirect labelling (procedures with bifunctional
chelates) (4).
This experimental study is focused on the methods of direct
labelling. Generally speaking, they are methods based on the use
of functional groups naturally occurring in proteins or peptides in
the form of -NH2, -OH, -COOH or -SH, which are either free in the
native protein, or released during its modification. Under certain
structural conditions, these groups are capable of binding reduced
technetium. Two different binding sites have been suggested:
a) high affinity and low capacity, associated with SH groups (5),
b) low affinity and high binding site capacity, associated with
free -NH2, -OH and COOH groups.
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Abstract
BACKGROUND: Our research into new methods of labelling
biologically active substances with technetium (99mTc) to be used
in nuclear medicine is focused on proteins and peptides whose
labelling is difficult and continues to pose a problem. Use of
redox polymers is the gentlest method as there is no need to
use other compounds to modify reaction conditions, as is the
way with the currently employed methods.
METHODS: Kits containing proteins, e.g., human immunoglo-
bulin (IgG), human leukocytes dialysate (HLD), were labelled
with 99mTc using a redox polymer (RP-IDA) and/or using reduc-
tion of pertechnetate (99mTc) with stannous chloride. The radio-
chemical purity was evaluated using paper and/or electrophore-
sis of the labelled proteins. The results were confirmed by col-
umn chromatography of the labelled IgG.
RESULTS: Use of a redox polymer for labelling raises the stabil-
ity of 99mTc labelled proteins so that labelling efficiency remains
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A drawback of direct labelling procedures is that technetium
may bind to these quite different binding sites with high and low
affinity. This usually leads to variable stability of the labelled prod-
uct. For this reason, we focused on the preparation of protein and
peptide kits for labelling by technetium (99mTc) using redox polymers
which, in our view, is the gentlest method. Use of redox polymers at
pH values over 6.0 allows practically selective labelling of these com-
pounds with technetium (99mTc) at end SH groups. Redox polymers
do not require the use of other adjuvants to modify reaction condi-
tions as is necessary with the currently used methods (6).
In nuclear medicine, proteins isolated from human blood, e.g.,
serum albumin, immunoglobulins, monoclonal antibodies (7), and
peptides of varied molecular weight are employed as radiopharma-
ceuticals (810). Their labelling using redox polymers may eliminate
the problems encountered in the preparation of these radiophar-
maceuticals and raise the stability of labelled compounds (11, 12).
In this study we selectedfor technetium (99mTc) labelling us-
ing redox polymershuman immunoglobulin and dialysate of
human leukocytes.
Materials and methods
Chemicals
Human immunoglobulin (IgG-5% solution containing minimally 95%
of monomer and dimer of IgG), NIGA-SEVAC a.s. Prague,
Human leukocytes dialysate (HLD), IMMODIN-SEVAC a.s. Prague,
Sodium pertechnetate(99mTc)  (Ultratechnecow FM generator),
Mallinckrodt Medical,
Stannous chloride dihydrate (Merck),
Redox polymer (RP-IDA), FNKV Prague.
Preparation of the kits
5 ml of the protein solution was mixed with 500 mg of redox poly-
mer RP-IDA. The synthesis of redox polymers with IDA functional
groups from the dextran matrix is described in our previous paper
(13). Alternatively, ligands of these proteins were labelled with 99mTc
by reduction of pertechnetate (99mTc) without a redox polymer us-
ing kits prepared by mixing of 5 ml of the protein solution with 5 µl
of stannous chloride dihydrate solution (0.25 mg). After stirring for
16 hr at room temperature, a mixture of the ligand with redox poly-
mer or solution of protein with stannous chloride was filtered
through a 0.22 µm pore size filter and the solution was filled per
0.2 ml into sterile vials. All steps were performed in nitrogen atmo-
sphere. Kits were stored at 35o C.
Labelling with 99mTc
After reconstruction of the kit, 2 ml of sodium pertechnetate (99mTc)
solution were added. The reaction was terminated after 15 min
incubation at room temperature.
Radiochemical purity assessment
Our methods of control were limited to paper and column chro-
matography and electrophoresis.
Paper: Whatmann No. 3, ascending. 10 cm distance, solvent: Ac-
etone 90%
Column: Sephadex G-50 (30x1 cm), solvent: Saline
Electrophoresis: Paper: Cellulose acetate, Solvent: Borate buffer pH 9,
Current: 500 V/40 min
Results
Labelling efficiency
Samples of a solution of immunoglobulin and human leukocyte
dialysate labelled with technetium (99mTc) with the help of a redox
polymer (RP-IDA) showed a high labelling efficiency. Use of a re-
dox polymer also has a positive effect on the stability of the la-
belled compounds. When not using redox polymers for protein
labelling, the labelling efficiency declines by more than 50% after
30 hours. The results are shown in Table 1.
One month after kit preparation, proteins labelled using redox
polymers exhibit high efficiency of 99mTc binding throughout the
shelf life of the radionuclide.
As evident from Table 2, technetium (99mTc) tends to get re-
leased from compounds with proteins labelled not using redox
polymers.
Table 1. Labelling efficiency of kits prepared using RP-IDA
Labelling efficiency (%)
Time since 99mTc-IgG 99mTc-HLD
labelling (hrs) RP-IDA Sn2+ RP-IDA Sn2+
0 97.0 95.2 98.9 95.8
4 98.9 94.2 98.8 94.3
6 97.6 93.9 98.4 94.2
8 98.2 92.4 98.2 93.6
24 98.7 63.2 98.0 55.7
30 98.3 42.0 95.6 46.4
Table 2. Stability of the labelled kits 1 month after their preparation
expressed in terms 99mTc labelling efficiency
Labelling efficiency (%)
Time since 99mTc-IgG 99mTc-HLD
labelling (hrs) RP-IDA Sn2+ RP-IDA Sn2+
0 96.7 95.5 97.6 93.1
4 95.9 94.2 97.7 91.3
6 95.8 93.9 97.2 89.3
8 95.3 92.4 96.1 82.9
24 95.0 68.2 96.8 55.6
Table 3. Stability of the kits expressed as 99mTc labelling efficiency
Labelling efficiency (%)
Time since kit 99mTc-IgG 99mTc-HLD
preparation (days) RP-IDA Sn2+ RP-IDA Sn2+
0 97.1 95.5 98.2 96.1
1 97.0 95.2 98.2 96.3
2 95.4 93.2 98.0 92.8
7 95.2 89.5 98.7 91.4
30 95.0 72.3 97.6 93.1
50 92.7 63.4 98.1 88.9
100 90.9 turbidity 97.1 87.5
150 89.0 turbidity 98.0 87.2
300 87.0 turbidity 97.5 87.4
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Another important finding is the long-term stability of kits pre-
pared with HLD prepared using a redox polymer. As shown by
data in Table 3, the labelling efficiency of HLD- and IgG-contain-
ing kits did not decrease below 97% and 87%, respectively, at 300
days; kits prepared without using a redox polymer for direct label-
ling with 99mTc are not stable.
while 1.5% of the activity at most belonged to pertechnetate (99mTc).
These results are in Table 4.
Discussion
When labelling protein-like substances with technetium (99mTc), the
reductant employed is Sn2+ in the form of stannous chloride in
acid medium (below pH 2.6). The drawbacks of this method in-
clude the possible inactivation of biologically active proteins as
well as the formation of colloids when adjusting pH to optimal
values. The method using various complexes of Sn2+ to transfer
this ion to protein also leads to protein contamination with Sn2+
complexes with possible formation of colloids, which are practi-
cally unable to be removed from the reaction mixture. It is for
these reasons that we employ, when using biologically active
substances for labelling with 99mTc, insoluble redox polymers on
the basis of cross-linked dextran.
Use of redox polymers is intended especially for the labelling
of labile structures and substances sensitive to reaction condi-
tions. In these, the possibility of incorporating of chelating groups
anchoring to proteins that can make them inactive is virtually ruled
out. As results, labelling of proteins with technetium (99mTc) using
redox polymers for use in nuclear medicine is most promising.
This will provide the opportunity to prepare radiopharmaceuticals
in a kit form which can be readily labelled with technetium (99mTc)
attaining high radiochemical purity and stability.
Table 4. Radiochemical purity of 99mTc-IgG prepared using RP-IDA
Component Labelling efficiency (%)
99mTc-IgG 96.0
99mTc-hydrolysed 2.5
99mTcO4
- 1.5
The efficiency of protein labelling with technetium (99mTc) and
the radiochemical purity in labelled IgG was evaluated by electro-
phoresis on cellulose acetate in borate buffer. The course of the
electrophoregram is shown in Figure 1.
As can be seen in Figure 1 and when compared with Table 4,
the radiochemical purity of labelled protein is high (96 % 99mTc-IgG,
2.5 % hydrolysed form, 0.5 % 99mTcO4
-).
These results were confirmed by column chromatography
where 99mTc-IgG was eluted with a maximum peak between 12 to
22 ml. Free pertechnetate (99mTc) was found to elute between 38
and 44 ml. The fraction of 99mTc-IgG contained 96% of the activity,
Electronic Res: Mod Bkgnd: POZADI.R01 Norm: NORMALA.R01 Base Correct: On
Run Time: 1:01 Total Counts: 239001 Total CPM: 235083.3
Total count region: 5mm 200mm
Name Start End Max RF Region Region % of % of
(mm) (mm) (mm) Counts CPM Total ROIs
Rgn 1 0.4 17.1 8.1 0.041 5901 5804.0 2.47 2.57
Rgn 2 40.6 90.7 62.5 0.313 222203 218560.2 92.97 96.89
Rgn3 180.6 199.4 194.7 0.974 1227 1207.3 0.51 0.54
3 Peaks 229331 225571.5 95.95 100.0
Figure 1. Electrophoresis of 99mTc-IgG prepared using RP-IDA (Rgn 1  hydrolysed 99mTc,
Rgn 2  99mTc-IgG 2, Rgn 3  99mTcO4 ).
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Conclusions
When using the method for direct protein and peptide labelling by
99mTc with the help of a redox polymer, the result is practically se-
lective labelling at free end SH groups.
The radiochemical purity and stability of 99mTc labelled pro-
teins depends on the degree of cross-linking of the redox poly-
mer dextran matrix and on the chemical structure of end function-
al groups anchored in the dextran matrix.
After labelling with 99mTc, proteins and peptides prepared into
kit form using this method show high radiochemical purity and
stability. These kits also show high stability when stored frozen
(300 days).
The method for preparing protein- and peptide-containing kits
using RP-IDA is the gentlest technique developed to date and al-
lows the use of single-compound kits without adjuvants while re-
taining high radiochemical purity and stability of the labelled pro-
teins and peptides.
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